Treatment of MRL/lpr mice with HDAC inhibitors also had therapeutic effects, with improvement of proteinuria, reduced renal damage and down-regulation of lupus-associated cytokine levels [87]. The gene discussed is HDAC9; the disease is systemic lupus erythematosus.